Introduction:Basic information about CAS 446022-33-9|Pelitrexol, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Pelitrexol |
|---|
| CAS Number | 446022-33-9 | Molecular Weight | 463.507 |
|---|
| Density | 1.6±0.1 g/cm3 | Boiling Point | / |
|---|
| Molecular Formula | C20H25N5O6S | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | N-((5-(2-((6S)-2-Amino-1,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl)ethyl)-4-methyl-2-thienyl)carbonyl)-L-glutamic acid |
|---|
| Synonym | More Synonyms |
|---|
Pelitrexol BiologicalActivity
| Description | Pelitrexol (AG 2037) is an inhibitor of glycinamide ribonucleotide formyltransferase (GARFT). |
|---|
| Related Catalog | Signaling Pathways >>Others >>OthersResearch Areas >>Cancer |
|---|
| Target | GARFT[1] |
|---|
| References | [1]. Emmanuel N, et al. Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase. Cell Rep. 2017 Jun 27;19(13):2665-2680. |
|---|
Chemical & Physical Properties
| Density | 1.6±0.1 g/cm3 |
|---|
| Molecular Formula | C20H25N5O6S |
|---|
| Molecular Weight | 463.507 |
|---|
| Exact Mass | 463.152557 |
|---|
| PSA | 215.74000 |
|---|
| LogP | -0.58 |
|---|
| Index of Refraction | 1.743 |
|---|
| InChIKey | QXOPTIPQEVJERB-JQWIXIFHSA-N |
|---|
| SMILES | Cc1cc(C(=O)NC(CCC(=O)O)C(=O)O)sc1CCC1CNc2nc(N)[nH]c(=O)c2C1 |
|---|
Synonyms
| L-Glutamic acid, N-[[5-[2-[(6S)-2-amino-3,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl]ethyl]-4-methyl-2-thienyl]carbonyl]- |
| N-[(5-{2-[(6S)-2-Amino-4-oxo-1,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl}-4-methyl-2-thienyl)carbonyl]-L-glutamic acid |
| (2S)-2-(((5-(2-((6S)-2-Amino-4-oxo-1,4,5,6,7,8-hexahydropyrido(2,3-D)pyrimidin-6-yl)ethyl)-4-methylthiophen-2-yl)carbonyl)amino)pentanedioic acid |
| Ag2037 |
| Pelitrexol |
| Unii-dht6E8m4kp |
| L-Glutamic acid,N-((5-(2-((6S)-2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido(2,3-D)pyrimidin-6-yl)ethyl)-4-methyl-2-thienyl)carbonyl) |